Episode 1: After a scientist dies under suspicious circumstances, journalist Terry Corcoran begins investigating Chemacran, the pharmaceutical company where the deceased was formerly employed. Chemacran is in the midst of a lucrative merger, thanks to the success of its antidepressant, Seraban. Meanwhile, fellow reporter Maureen Boland tries to get the scoop on J.P. O'Farrell, Chemacran's managing director.